Atelerix supports lifetime CDT
The EPSRC-SFI Joint Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (lifETIME CDT) is a partnership
Atelerix presents promising data for the application of its technology LeukoStor™ to CAR-T Cell Therapy Manufacturing
One of the biggest challenges faced by CAR-T Cell manufacturers is the variability among apheresis product, which can negatively impact
BeadReady™ & Bioprinting MSC Spheroids
The population of haematopoietic stem cells (HSCs) found in our bone marrow are responsible for repopulating the body with all
Atelerix presents promising data for the application of its technology LeukoStor™ to Monocyte Preservation
Peripheral blood mononuclear cells (PBMCs), derived from whole blood or leukapheresis, encompass several major immune cell populations including lymphocytes, monocytes,
New distributor agreement between Atelerix and BioBench Solutions LLP
New distributor agreement between Atelerix (UK) and BioBench Solutions LLP (India). We are proud to announce the beginning of a
New patent application published!
Atelerix’s newest patent application extends protection to preserving viruses Atelerix has received notification that its newest patent application has
Atelerix launches its new product CytoStor™
We are excited to announce the release of the newest addition in our hypothermic cell and virus preservation range. CytoStor’s
New Product Release! Introducing TissueReady™
TissueReady™ offers a simple solution that preserves the viability and quality of fresh tissue at ambient temperatures, increasing shelf life,
